Screening tests are widely used in medicine to assess the likelihood that members of a
defined population have a particular disease. This article presents an overview of such tests …

Background Cervical cancer screening has traditionally been based on cervical cytology.
Given the aetiological relationship between human papillomavirus (HPV) infection and …

Over 8000 phenolics have been discovered in plants to the present. Flavonoids, including
flavonols, flavones, isoflavones, anthocyanidins, resveratrol, curcumin, tannins, lignans, and …

Although most cervical human papillomavirus type 16 (HPV16) infections become
undetectable within 1–2 years, persistent HPV16 causes half of all cervical cancers. We …

This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Description: Update of the 2003 US Preventive Services Task Force (USPSTF) …

Early detection represents one of the most promising approaches to reducing the growing
cancer burden. It already has a key role in the management of cervical and breast cancer …

Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical
cancer, the second most frequently occurring cancer in women worldwide. Rates of …

Several studies suggest that HPV testing is more sensitive than cytology in primary cervical
screening. These studies had different designs and were reported in different ways …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

Background Approximately 20 percent of adults become infected with human papillomavirus
type 16 (HPV-16). Although most infections are benign, some progress to anogenital cancer …